CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 175	$ 315
Accounts receivable, net of allowance for credit losses of $30 as of both March 31, 2023 and December 31, 2022	1,254	1,195
Inventories	190	192
Prepaid expenses and other current assets	195	196
Total current assets	1,814	1,898
Property, plant and equipment, net	1,795	1,766
Operating lease right-of-use assets	589	585
Goodwill	7,241	7,220
Intangible assets, net	1,077	1,092
Investments in equity method investees	128	132
Other assets	150	144
Total assets	12,794	12,837
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,198	1,396
Current portion of long-term debt	2	2
Current portion of long-term operating lease liabilities	155	153
Total current liabilities	1,355	1,551
Long-term debt	3,975	3,978
Long-term operating lease liabilities	490	489
Other liabilities	809	812
Commitments and contingencies
Redeemable noncontrolling interest	77	77
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2023 and December 31, 2022; 162 shares issued as of both March 31, 2023 and December 31, 2022	2	2
Additional paid-in capital	2,266	2,295
Retained earnings	8,412	8,290
Accumulated other comprehensive loss	(18)	(21)
Treasury stock, at cost; 50 and 51 shares as of March 31, 2023 and December 31, 2022, respectively	(4,612)	(4,673)
Total Quest Diagnostics stockholders' equity	6,050	5,893
Noncontrolling interests	38	37
Total stockholders' equity	6,088	5,930
Total liabilities and stockholders' equity	$ 12,794	$ 12,837